ERA4Health: Joint Transnational Call for Investigator-Initiated Clinical Studies 2025

Joint Transnational Call for Investigator-Initiated Clinical Studies (JTC IICS) – 2025 “Fostering Pragmatic Comparative-Effectiveness Trials in Non-communicable Diseases” (EffecTrial) Aim of the Call The aims of the call are: to support randomised, interventional and pragmatic comparative-effectiveness multi-country Investigator-Initiated Clinical Studies (IICS). to encourage and enable transnational collaboration between clinical/public health research teams (from hospital/ public health, healthcare settings and other healthcare organisations) that conduct comparative-effectiveness multi-country IICS. Applicants Eligility Criteria Only transnational studies will be funded. The following conditions (among the others) apply to the composition of consortia: A minimum of 3 (three) and a maximum of 5 (five) countries should be represented in the consortium (the countries of the collaborators are not considered in this number) If a partner is eligible by a funding organisation, which will grant a single partner, only one national partner should be a part of the consortium. This partner will have the opportunity to establish a collaboration agreement with other additional national recruiting sites and allocate a budget to the recruitment sites. Those recruitment sites will be associated partners to the consortium. The maximum number of countries can be increased to 6 (six) or 7 (seven) if they include 1 (one) or 2...